Intas Pharmaceuticals

Rediff.com » News » Intas Pharmaceuticals

News for Intas Pharmaceuticals

Business

Why Zydus is likely to continue with its outperformance

Even as most of its large-cap pharmaceutical peers have struggled to stay above water on the returns front, Zydus Lifesciences has been one of the big outperformers within the sector over the past......

PE/VC investments in pharma cos cross $1 bn mark

Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma......

Indian pharma firms working on new repurposed drug for Covid-19

Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations. Domestic drug firms are working on re-purposed drugs that......

'Famotidine may become the next HCQ for Covid-19'

Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its......

Gujarat pharma hub hit by near-zero exports

With the government asking the companies to operate with only 50 per cent staff strength, and exports dipping to almost zero, the truck and bus drivers idling at the petrol pump say they hardly......

Rediff News

Intas Pharmaceuticals

News for Intas Pharmaceuticals

Why Zydus is likely to continue with its outperformance

PE/VC investments in pharma cos cross $1 bn mark

Indian pharma firms working on new repurposed drug for Covid-19

'Famotidine may become the next HCQ for Covid-19'

Gujarat pharma hub hit by near-zero exports

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS